In the high-stakes world of pharmaceutical innovation, the ability to accurately track patent landscapes isn’t just a matter of operational efficiency—it’s a strategic imperative. Yet, many organizations rely heavily on Excel spreadsheets for patent mo…

In the high-stakes world of pharmaceuticals, timing is everything. When a blockbuster drug’s patent expires, the race to capture market share begins—not just among generic manufacturers, but across the entire healthcare ecosystem. Yet, many companies f…

The Myth of the Patent Cliff: Why Revenue Declines Are Not Inevitable—and What Pharma Leaders Must Do About It
In the high-stakes world of pharmaceuticals, the looming specter of the patent cliff has long haunted executives and investors alike. Convent…

In the high-stakes world of pharmaceuticals, the race to bring generics to market isn’t just about regulatory approval or manufacturing capacity — it’s a complex chess game played behind closed doors, often hidden from public view. For years, industry …

The Iceberg Illusion: Why Tracking Drug Expiry Dates Is the Least of Your Patent Risks
In the high-stakes world of pharmaceutical innovation, it’s easy to get caught up in the minutiae—tracking expiry dates, managing patent deadlines, and ensuring comp…

In the high-stakes world of pharmaceutical innovation, the line between legitimate marketing and legal peril has become increasingly blurred. The recent exposé on the erosion of the “safe harbor” doctrine and the rise of “skinny labels” reveals a troub…

In the high-stakes arena of modern pharmaceuticals, few battles are as intense—and as consequential—as the ongoing war over biologic intellectual property (IP). As biotech giants and emerging startups vie for dominance, the landscape is rapidly evolvin…

The Challenger’s Playbook: How Generic Drug Companies Are Turning Patent Battles into Market Wins
In the high-stakes world of pharmaceuticals, patent litigation has long been viewed as a battleground—an obstacle that generic drug companies must overcom…

In the high-stakes world of pharmaceutical innovation, the battle over patent rights can shape the future of healthcare, influence market dynamics, and determine the accessibility of life-saving treatments. Recently, a pivotal legal case has emerged th…

In the high-stakes world of pharmaceutical innovation, the battle over patent rights isn’t just a legal skirmish—it’s a defining moment that can shape the future of healthcare and industry leadership. Recently, the case of Actelion Pharmaceuticals US I…